Google News

Simcere Zaiming, Roche Ink License Agreement for Antibody Targeting B-Cell-Mediated Diseases - Contract Pharma

Sep 1, 2026, 3:36 PM

Translate article text

Choose a language and wait for the translated text.

Simcere Zaiming, Roche Ink License Agreement for Antibody Targeting B-Cell-Mediated Diseases  Contract Pharma